Shoyinka? Here’s what the numbers say. Plus a look at a challenging New York Giants defensive line in Week 10.

Q3 2025 Earnings Call Transcript November 10, 2025 ADC Therapeutics S.A. beats earnings expectations. Reported EPS is ...

Foods that give you energy are rich in nutrients the body needs to keep you going from dawn to dusk. A nutritionist shares ...

For single mum-of-four Abi, the debts she has built up by using buy now, pay later (BNPL) services have left her trapped in a ...

The Ford Kuga still makes a decent case for itself on paper, and its driving dynamics set it apart. But it’s getting on these ...

For public companies looking to raise capital relatively quickly and at a lower cost, equity lines of credit (ELOCs) and at-the-market ...

The Acer Predator X34 X0 is an affordable Mini-LED monitor that delivers a bright and vivid image with good HDR and contrast, ...

Also, how do Jordan Spence's defensive rankings compare to his teammates? And a look at improvements on the penalty kill.

Amplitude reported 18% revenue growth in the third quarter to $88.6 million, well ahead of the consensus at $86.3 million. On ...

A second in-house developed system is BetterX from South Carolina-based Better Collision Centers. Founder and CEO Jonathon ...

Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI.

Eye-specific differences in presynaptic release site addition and clustering correlate with axonal segregation outcomes during retinogeniculate refinement in the mouse.